Role of pyrophosphate in vascular calcification in chronic kidney disease Daniel Azpiazu, Sergio Gonzalo, Emilio González-Parra, Jesús Egido, Ricardo Villa-Bellosta

Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto, Haerani Rasyid, Anastasya Angelica Vicente, Winny Suciangto

Healthcare resource utilization and costs of chronic kidney disease in Spain across KDIGO categories: Insights from real-world evidence Rafael Santamaria, Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel, Ignacio Hernández, Ana Cebrián, Roberto Alcázar, Manuel Gorostidi